Prihlásiť sa Zaregistrujte sa zadarmo

Pomer krátenia spoločnosti Akari Therapeutics Plc

Aká je hodnota metriky Pomer krátenia spoločnosti Akari Therapeutics Plc?

Hodnota metriky Pomer krátenia spoločnosti Akari Therapeutics Plc je 0.65

Aká je definícia metriky Pomer krátenia?



Pomer krátenia (Short ratio) je pomer akcií predaných na krátko a priemerným denným objemom.

Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.

The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.

Pomer krátenia spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Akari Therapeutics Plc

Čomu sa venuje spoločnosť Akari Therapeutics Plc?

akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.

Firmy s metrikou pomer krátenia podobnou spoločnosti Akari Therapeutics Plc